INTRODUCTION N
Inn addition to the identification of the sentinel node, the success of the procedure is determined byy a low false negative rate. Few authors, however, discuss the following two questions: what wentt wrong in the false negative cases and what can be done to avoidd these failures in the future. Inn this study, we share our experience with false negative sentinel node biopsies in palpable and non-palpablee breast cancer patients and discuss what we have learned from these cases.
MATERIALSS AND METHODS
Betweenn January 1997 and November 2001, 599 cNO breast cancer patients underwent sentinel nodee biopsy at The Netherlands Cancer Institute. Seven patients had a bilateral tumor and 112 patientss a non-palpable tumor. Pathologic proof of breast cancer was routinely obtained by core biopsyy or fine needle aspiration and the primary tumor was still present in all patients. Routine axillaryy clearance was performed until January 1999 in 81 patients as part of the learning phase. Inn the subsequent patients, axillary clearance was omitted in the case of a tumor-negative axillaryy sentinel node. Since November 1999, all patients had preoperative axillary ultrasonographyy to ensure the cNO status. The median follow-up duration of patients studied afterr the learning phase was sixteen months (range 1-34). AA two-day protocol was used. On the day before surgery.
Wm Tc-nanocolloid (Nanocoll®, Amershamm Cygne, Eindhoven, the Netherlands) was injected into the lesion in a mean volume off 0.2 ml and a mean radioactivity dose of 105.4 MBq (2.8 mCi). In case of non-palpable breast cancer,, the intratumoral injection was guided by ultrasound or stereotaxis. Immediate dynamic imagingg was performed followed by static imaging at 30 minutes and four hours post-injection. AA dual-head gamma camera (ADAC Vertex®, Milpitas, California, U.S.A.) was used. Since July 1999,, additional views were made after two hours (455 cases) and in August 2000 dynamic imagingg was abandoned (236 cases). Both anterior and lateral images were obtained. The locationn of the node was marked on the skin with indelible ink. After the last lymphoscintigraphy,, a localization wire with a catheter was positioned in the non-palpable tumors.. The next day. patent blue dye (Laboratoire Guerbet, Aulnay-Sous-Bois, France) in a meann volume of 1.0 ml was administered into the palpable lesion or through the catheter. Intraoperativee detection of radioactivity was measured with a gamma ray detection probe (Neoprobe",, Johnson & Johnson Medical, Hamburg, Germany). Both tracers were used to identifyy the sentinel node. All procedures were performed by one of four experienced surgeons orr under their supervision by a resident or fellow. A hot spot on the lymphoscintigram was consideredd to be a sentinel node if an afferent lymphatic channel was visualized, the hot spot wass the first one seen in a sequential pattern, or the hot spot was the only one depicted. An afferentt blue lymphatic vessel coming directly from the tumor also defined a node as the sentinel node.. Our policy is to perform a complete axillary lymph node dissection if no sentinel node can bee identified during surgery. These cases are not defined as false negative, because no sentinel nodee has been removed. Alll sentinel nodes were formalin-fixated, bisected, paraffin-embedded and cut at a minimum of sixx levels at 50 to 150 urn intervals. On most sentinel nodes a frozen section was performed.
Pathologicall evaluation included hematoxylin-eosin and immuno-histochemical staining (CAM 5.2,, Becton Dickinson, San Jose, California, U.S.A.). Immuno-histochemical staining was also performedd on the lymph nodes in the remainder of the axilla during the learning phase. AA sentinel node procedure was considered false negative if the initial pathology evaluation revealedd no tumor cells in the sentinel node white one or more non-sentinel nodes were tumor- AA 44 year-old woman presented with a 1.7 cm left breast cancer. On the day before surgery at 8:588 AM. a total of 88.0 MBq (2.4 mCi) Wm Tc-nanocolloid was injected into the lesion. The last lymphoscintigraphyy image (four-hour scan) was reported as showing one axillary sentinel node andd no second-echelon nodes. Because of a conflicting schedule, the surgeons were forced to postponee the operation until the afternoon. At 2:30 PM a volume of 1 ml patent blue dye was administeredd into the lesion. A 4-cm incision was made along the lower hairline of the left axilla.. After tracing a blue lymphatic vessel, a blue node was found with a disappointing amount off radioactivity (seventeen counts per second and a background of eight counts per second). The existencee of a second sentinel node was considered and exploration was continued. One additionall blue lymphatic vessel could be identified, leading to an unstained node with again a loww count rate. After harvesting two additional non-blue, low-radioactive nodes, the axilla still showedd some radioactivity. At this point the surgeons decided to perform the wide local excisionn of the primary tumor first. In this way they hoped to lower the background radiation. Nevertheless,, no other clear hot or blue nodes could be identified. At that time, intra-operative palpationn of the axilla was not routinely performed. A total of three sentinel nodes and one nonsentinell node were submitted for pathological evaluation. Because this patient was operated duringg the learning phase, a completing axillary lymph node dissection was performed. Alll three sentinel nodes and the non-sentinel node were free from metastases. The axillary lymphh node dissection specimen contained seventeen additional nodes. Five of these nodes showedd metastatic foci, with a size of 2 mm to 1.2 cm. The primary tumor was a 1.7 cm infiltratingg ductal carcinoma grade III. Thee left breast, axilla and parasternal region were treated with radiotherapy. Adjuvant systemic chemotherapyy was instituted, followed by Tamoxifen. Forty months later, the patient was doing welll without evidence of disease. Remarks:Remarks: A 30 hour delay and a physical half-life of six hours leave us with a mere 3.1% of the injectedd radioactivity dose at the time of surgery. Beside that, most of the tracer stays at the injectionn site. After 24 hours, the median uptake in a sentinel node is just 0. W7c of the injected dose.. This is sufficient for the injected amount of radioactivity. With these facts in mind, one mustt conclude that the extra delay in this patient is accountable for creating a situation in which thee intraoperative assistance of the radioactive tracer is diminished. If surgery takes place the nextt day. it should be done as the first case in the morning." In our 599 patients the mean time intervall was 23.5 hours (range 18.5 -31). thus within the acceptable 24 hours range.
CASEE 2A
AA 44 year-old woman presented with a 1.8 cm left breast cancer. Lymphoscintigraphy showed onee sentinel node in the axilla. No second-echelon nodes were seen. The next morning, a volumee of 1.0 ml patent blue dye was injected into the lesion. A blue lymphatic vessel was identifiedd and followed to a threesome of nodes. One node was only blue, the second was only radioactivee and the third one was neither. The first two nodes were considered to be the sentinel nodess and were removed. The primary tumor was excised. Neitherr one of the two sentinel nodes showed evidence of tumor at pathological evaluation. The primaryy tumor was a 1.8 cm infiltrating ductal carcinoma grade II. Thee left breast was treated with radiotherapy. No adjuvant systemic chemotherapy was instituted.. After 21 months, the patient presented with a palpable left axillary recurrence for whichh she underwent an axillary lymph node dissection. Pathological evaluation of the axillary lymphh node dissection specimen showed massive tumor invasion and lymph nodes were hardly recognizable.. Adjuvant radiotherapy to the axilla, supraclavicular and parasternal regions was givenn as well as chemotherapy and Tamoxifen. The patient was doing well with no evidence of diseasee three years after the first operation. The pathologist was asked to review the original sentinell nodes. Additional serial sectioning of these nodes revealed two clusters of approximatelyy ten tumor cells in the marginal sinus of one sentinel node. Remarks:Remarks: This false negative sentinel node procedure was due to a pathological sampling error. Twoo other patients in our series were initially reported to have tumor-negative sentinel nodes andd tumor-positive second-echelon nodes (no. 2b and 2c in the table). In case 2b a tumorpositivee non-sentinel node was found in the lateral part of a simple mastectomy specimen. After palpationn of the biopsy wound in case 2c. a suspicious non-sentinel node was harvested and foundd to be tumor-positive. Additional serial sectioning of the sentinel nodes of both patients showedd micrometastases after all.
CASEE 3A
AA 46 year-old woman presented with a 2.1 cm right breast cancer. Lymphoscintigraphy demonstratedd one axillary sentinel node with two second-echelon nodes. During surgical exploration,, a blue lymphatic vessel was followed to a blue-stained, radioactive node. The sentinell node was harvested. Palpation of the biopsy wound revealed two firm lymph nodes of lesss than 1 cm, which were neither radioactive nor blue. Both nodes were removed because they feltt suspicious. On frozen section examination, the sentinel node was found to be free of disease, butt one of the two non-sentinel nodes was tumor-positive. A wide local excision of the primary tumorr was performed followed by a complete axillary lymph node dissection. Seriall sectioning of the sentinel node at fourteen levels confirmed the tumor-negative result of thee frozen section investigation. The involved non-sentinel node was 0.4 cm and showed massivee tumor invasion. One of the other eighteen axillary lymph nodes contained metastasis as well.. The primary tumor was a 2.1 cm infiltrating ductal carcinoma grade II. Thee right breast, axilla and parasternal region were treated with radiotherapy. Adjuvant systemic chemotherapyy was instituted, followed by Tamoxifen. The patient was doing well without evidencee of disease 26 months later.
Remarks:Remarks: One additional patient (no. 3b in the Table) was similar to Case 3a. A tumor-positive non-sentinell node was found in the axilla by means of intra-operative palpation. A complete axillaryy lymph node dissection was performed. She was free of tumor and doing well eight monthss later. Lymphh flow obstruction by tumor within the node is the presumptive cause in these cases. Uptakee of the radioactive tracer and the patent blue dye will not occur if a sentinel node is completelyy invaded by tumor. The lymph flow will be rerouted to a wo-sentinel node and so willl be the tracers. How can we recognize this feature? Sometimes it is possible to identify a bluee lymphatic vessel approaching a node and stopping right in front of it, without actually stainingg the node. In these cases blocking of the dye by tumor inside the node must be consideredd and such a node should be named the sentinel node. We have experienced that palpationn of the biopsy wound may be helpful. In this way solid lymph nodes might be detected whichh could not be felt through the skin at physical examination. Preoperative axillary ultrasonographyy also provides information about the lymph node status. Both preoperative ultrasonographyy and intraoperative palpation have now become standard at our institution. CASEE 4 Ann 84year-old woman presented with a 2.1 cm left breast cancer. Lymphoscintigraphy showed onee sentinel node and one second-echelon node in the axilla. Before the incision, at 8:30 AM, a volumee of 1.0 ml patent blue dye was injected into the lesion. A blue lymphatic vessel was followedd to a radioactive and blue node. Another blue and radioactive node was found very closee to the first and both were harvested. No other suspicious lymph nodes were found after palpationn of the biopsy wound. The primary tumor was excised by means of a simple mastectomy.. Both nodes were free of metastatic tumor. In the lateral part of the mastectomy specimen,, ten additional lymph nodes were found. Two of them contained metastases: 0.5 mm andd 4-mm. Additional serial sectioning of the sentinel nodes still revealed no tumor cells. The primaryy tumor was a 2.1 cm infiltrating ductal carcinoma grade I. Adjuvantt hormone therapy was instituted (Tamoxifen). No radiotherapy was given because of cardiacc problems and advanced age. The patient was doing well without evidence of disease four monthss later. Remarks:Remarks: No cause could be found to explain this false negative procedure. CASEE 5 AA 43 year-old woman presented with a 3 cm left breast cancer. At 9:12 AM on the day before surgery,, a total of 63.1 MBq (1.7 mCi) """Tc-nanocolloid was injected into the lesion. One sentinell node and three second-echelon nodes were seen in the axilla. Before incision, at 11:17 AM,, a volume of 1.0 ml patent blue dye was injected around the lesion in the left breast. Intratumorall injection failed because the tumor was too solid. An incision was made along the lowerr hairline in the left axilla. A big blue lymphatic vessel was followed to a blue-stained. radioactivee node. A second blue vessel led to another blue-stained, radioactive node. After harvestingg both level I axillary nodes, scanning of the wound still showed some radioactivity in levell II of the axilla. Exploration of this area revealed one more radioactive node with a small bluee spot. Since this patient was part of the learning phase, a completing axillary lymph node dissectionn was performed in addition to a wide local excision of the primary tumor. Alll three sentinel nodes were free of tumor. The axillary lymph node dissection specimen containedd twelve additional nodes, one of which contained a micrometastasis in the marginal sinus.. The primary tumor was a 3 cm infiltrating ductal carcinoma grade II, with a slight in situ component. . Thee patient underwent a bilateral oophorectomy two months after breast surgery. Additional radiotherapyy was given to the left breast and parasternal region. She was doing well without evidencee of disease 34 months later.
Remarks:Remarks:
The unusual aspects of this procedure were the small amount of radioactivity, the longerr interval between lymphoscintigraphy and operation and the injection of the blue dye aroundd the tumor instead of into the actual lesion. However, no definite cause for the failure was identified. .
DISCISSION N
AA total of eight patients out of a group of 21 2 with a tumor-positive axilla had a false negative sentinell node biopsy. Only one of these eight patients developed an actual recurrence in the axilla.. Establishing the true incidence of axillary recurrence requires a longer period of followup,, but several lessons can already be learned from the false negative sentinel node procedures describedd above. First of all. it makes sense to perform the sentinel lymphadenectomy as early as possiblee because more counts facilitate i dent ill cat ion of the correct node. In a two-day protocol, thee sentinel node biopsy should be the first case in the morning.^ Intraoperative palpation of the biopsyy wound should be done during every procedure to diminish the chances of leaving behind involvedd nodes in the presence of a false negative sentinel node. The use of both a radioactive tracerr and blue dye has been shown to be preferable to the use of a single agent. Wong et al. supportedd the fact that injection of both tracers improved the ability to detect multiple sentinel nodes.^^ Case 2a demonstrates again that a sentinel node can be only blue or only radioactive. For pathologicall evaluation a minimum amount of three slices at a maximum of 250 urn intervals is recommendedd in the Netherlands.' 1 At our institute, almost all sentinel nodes are first cut in half.
Att least three slices of 50 to 150 mn are then made of both parts, for a total of seven slides includingg the frozen section. Although in some cases this was not enough, we feel that our protocoll strikes a balance between sensitivity and work load for the pathologist. A total of 1200 sentinell nodes were pathologically examined in the present series of patients. The pathological falsee negative rate is three out of 221 tumor-positive sentinel nodes so far (1.3%). The chance thatt an initially reported tumor-negative node becomes positive after additional serial sectioning iss three out of 982 (0.3%), but we must emphasize that not all of these 982 sentinel nodes have beenn re-examined. If that were to be done, one might expect more false negative cases, although thiss does not mean that all these patients will develop axillary recurrence.
Furtherr reduction of the incidence of false negative sentinel node biopsies may be accomplished byy meticulous preoperative evaluation of the axilla including ultrasonography and fine needle aspirationn cytology of suspicious nodes. ' AA 1999 review of learning phase studies showed a wide variety of false negative rates: 0-40%. Subsequently,, three large observational studies showed just a single false negative case in patientss who did not undergo confirmatory axillary lymph node dissection after harvesting tumor-freee sentinel nodes. Veronesi et al. described 379 procedures with 285 tumor-negative sentinell nodes cases. 10 No axillary recurrences were observed but the follow up duration was stilll short with 343 person-years of risk. The authors expect that up to seven patients may recur inn the axilla in the future. A total of 133 patients with a median follow-up of 39 months (range: 24-511 months) and no axillary recurrences were described by Giuliano et al. In a series of 100 patientss with a median follow-up of 24 months, Roumen and coworkers encountered one patient withh axillary recurrence after a tumor-free sentinel node had been removed. " A review of the literaturee revealed just one other false negative case after abandoning routine axillary node dissection.. That case was seen at our institution and is included in the present series.
CONCLUSIONS S
Inn conclusion, a meticulous technique is necessary in sentinel node procedures in breast cancer patients.. Intraoperative palpation of the biopsy wound can identify suspicious lymph nodes. To furtherr reduce the false negative rate, we recommend preoperative ultrasonography of the axilla. Thee combination of both a radioactive tracer and blue dye is preferred and in a two-day protocol surgeryy must be performed first thing in the morning. Seven slices of 50 to 150 u.m strike an acceptablee balance between sensitivity and work load for the pathologist.
